GSK teams up with US university in Aids research

New York

YEARS ago, curing Aids was considered so out of the question that some scientists dared not even mention the possibility.

But in the latest sign that attitudes are changing, the British pharmaceutical giant GlaxoSmithKline is teaming up with the University of North Carolina at Chapel Hill to start a research institute and a company aimed at curing HIV infection and Aids.